BRIEF-Cannimed Therapeutics' Q2 loss per share $0.08
June 12, 2017 at 07:25 AM EDT
* Cannimed Therapeutics Inc reports financial results for Q2 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.